drugset / Trial / NCT00010309
Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma
Treatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have stage II, stage III, or stage IV melanoma.
Timeline
- Start
- 2000-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad2/MART-1v2 | Vaccine | — | — |
| Subject | gp100 antigen | Peptide | — | Other |